Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice

Factor VIII (FVIII) is an important component of blood coagulation as its congenital deficiency results in life-threatening bleeding. Current prophylactic therapy of the disease (hemophilia A) is based on 3–4 intravenous infusions of therapeutic FVIII per week. This poses a burden on patients, deman...

Descripción completa

Detalles Bibliográficos
Autor principal: Sarafanov, Andrey G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217895/
https://www.ncbi.nlm.nih.gov/pubmed/37239930
http://dx.doi.org/10.3390/ijms24108584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217895/
https://www.ncbi.nlm.nih.gov/pubmed/37239930
http://dx.doi.org/10.3390/ijms24108584

Ejemplares similares